David T Howton - Net Worth and Insider Trading
David T Howton Net Worth
The estimated net worth of David T Howton is at least $8 Million dollars as of 2024-05-03. David T Howton is the EVP, General Counsel of Sarepta Therapeutics Inc and owns about 31,871 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $4 Million. David T Howton is the SVP of Vertex Pharmaceuticals Inc and owns about 9,535 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $4 Million. David T Howton is also the COO of Solid Biosciences Inc and owns about 7,684 shares of Solid Biosciences Inc (SLDB) stock worth over $78,761. Details can be seen in David T Howton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David T Howton has not made any transactions after 2023-12-04 and currently still holds the listed stock(s).
Transaction Summary of David T Howton
David T Howton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David T Howton owns 3 companies in total, including Sarepta Therapeutics Inc (SRPT) , Vertex Pharmaceuticals Inc (VRTX) , and Solid Biosciences Inc (SLDB) .
Click here to see the complete history of David T Howton’s form 4 insider trades.
Insider Ownership Summary of David T Howton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SRPT | Sarepta Therapeutics Inc | 2020-06-22 | SVP & General Counsel |
| VRTX | Vertex Pharmaceuticals Inc | 2011-09-01 | SVP |
| SLDB | Solid Biosciences Inc | 2023-12-04 | See Remarks |
David T Howton Latest Holdings Summary
David T Howton currently owns a total of 3 stocks. Among these stocks, David T Howton owns 31,871 shares of Sarepta Therapeutics Inc (SRPT) as of June 22, 2020, with a value of $4 Million and a weighting of 51.66%. David T Howton owns 9,535 shares of Vertex Pharmaceuticals Inc (VRTX) as of September 1, 2011, with a value of $4 Million and a weighting of 47.36%. David T Howton also owns 7,684 shares of Solid Biosciences Inc (SLDB) as of December 4, 2023, with a value of $78,761 and a weighting of 0.98%.
Latest Holdings of David T Howton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics Inc | 2020-06-22 | 31,871 | 130.58 | 4,161,715 |
| VRTX | Vertex Pharmaceuticals Inc | 2011-09-01 | 9,535 | 400.16 | 3,815,526 |
| SLDB | Solid Biosciences Inc | 2023-12-04 | 7,684 | 10.25 | 78,761 |
Holding Weightings of David T Howton
David T Howton Form 4 Trading Tracker
According to the SEC Form 4 filings, David T Howton has made a total of 3 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Sarepta Therapeutics Inc is the sale of 105,122 shares on June 22, 2020, which brought David T Howton around $18 Million.
According to the SEC Form 4 filings, David T Howton has made a total of 0 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 328 shares on September 1, 2011, which brought David T Howton around $14,527.
According to the SEC Form 4 filings, David T Howton has made a total of 1 transactions in Solid Biosciences Inc (SLDB) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Solid Biosciences Inc is the sale of 5,367 shares on December 4, 2023, which brought David T Howton around $14,920.
Insider Trading History of David T Howton
- 1
David T Howton Trading Performance
David T Howton Ownership Network
David T Howton Owned Company Details
What does Sarepta Therapeutics Inc do?
Who are the key executives at Sarepta Therapeutics Inc?
David T Howton is the SVP & General Counsel of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Tech Ops Officer Bilal Arif , SVP & General Counsel Ryan Edward Brown , and Chief Financial Officer Ian Michael Estepan .
Sarepta Therapeutics Inc (SRPT) Insider Trades Summary
Over the past 18 months, David T Howton made no insider transaction in Sarepta Therapeutics Inc (SRPT). Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 68,532 shares made by Michael Andrew Chambers , a net sale of 30,000 shares made by Wigzell Hans Lennart Rudolf , and a net sale of 3,993 shares made by Stephen Mayo .
In summary, during the past 3 months, insiders sold 24,096 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 0 shares, with a net sale of 24,096 shares. During the past 18 months, 39,954 shares of Sarepta Therapeutics Inc (SRPT) were sold and 143,757 shares were bought by its insiders, resulting in a net purchase of 103,803 shares.
Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sarepta Therapeutics Inc Insider Transactions
David T Howton Mailing Address
Above is the net worth, insider trading, and ownership report for David T Howton. You might contact David T Howton via mailing address: Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
